Medifast, In A Buy Zone, Shows Rising RS Rating

Medifast, In A Buy Zone, Shows Rising RS Rating

Medifast had its Relative Strength (RS) Rating upgraded from 89 to 93 Tuesday. The IBD 50 stock is still inside a buy zone after clearing a 279.56 buy point in a consolidation. Once a stock moves 5% or higher beyond the initial entry, it's considered out of a proper buying area.